Lv2
170 积分 2020-09-23 加入
Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1)
2个月前
已完结
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
2个月前
已完结
The zonal anatomy of the prostate
2个月前
已完结
Anatomy of the prostate revisited: implications for prostate biopsy and zonal origins of prostate cancer
2个月前
已完结
HMGCS2 functions as a tumor suppressor and has a prognostic impact in prostate cancer
3个月前
已关闭
Metabolic-related gene signature model forecasts biochemical relapse in primary prostate cancer
3个月前
已完结
Genomic classifiers and prognosis of localized prostate cancer: a systematic review
3个月前
已完结
A Genomic Classifier Improves Prediction of Metastatic Disease Within 5 Years After Surgery in Node-negative High-risk Prostate Cancer Patients Managed by Radical Prostatectomy Without Adjuvant Therapy
3个月前
已完结
Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis
4个月前
已完结
Forces, Fluxes, and Fuels: Tracking mitochondrial metabolism by integrating measurements of membrane potential, respiration, and metabolites
4个月前
已完结
皖公网安备34019202002308
